banner

Zambiri zaife

Mbiri Yakampani

Innovita Biological Technology Co., Ltd. (pamodzi ndi nthambi zake, zomwe zimadziwika kuti "INNOVITA",) ndi kampani yaukadaulo yazachilengedwe yomwe imayang'ana kwambiri kafukufuku, chitukuko, kupanga ndi kugulitsa zinthu za in vitro diagnostic POCT. Zimapangidwa ndi Innovita (Tangshan) , Innovita (Beijing) ndi Innovita (Guangzhou).

● Anakhazikitsidwa mu 2006

● Konzani malo a R&D ku Beijing ndi Guangzhou, komanso malo opangira zinthu ku Qian'an, Hebei

about-us (3)
about-us (23)

Mbiri Yakampani

Yakhazikitsidwa mu 2006, INNOVITA wamanga nsanja zisanu ndi chimodzi luso monga antigen & antibody kukonzekera, kachilombo chikhalidwe, colloidal golide, ELISA, fluorescence chromatography, immunofluorescence, ndipo amachita Chinese National High-chatekinoloje R&D Program m'munda wa kafukufuku dziko lalikulu matenda opatsirana ndi ambiri. ntchito zina za umoyo wa anthu.Kupatula apo, INNOVITA ili ndi zovomerezeka zopitilira khumi zapadziko lonse ndikukhazikitsa Beijing R&D center, Guangzhou R&D center, Hebei kupanga maziko.Ndi zokambirana zazikulu zoyera, ndikukhazikitsa golide wa colloidal, ELISA, fluorescence chromatography, PCR, mizere yopangira ma immunofluorescence, INNOVITA wapeza CE ndi ISO13485 certification.

Pakalipano, mankhwala a INNOVITA ali ndi mayeso okhudzana ndi kupuma, kuyezetsa chonde, kuyesa kwa chiwindi, kuyesa kwa TORCH, kuyesa kwamtima, kuyesa kwa impso ndi zina zotero.Maukonde ogulitsa adakhudza zigawo zonse ndi zigawo ku China, ndikufalikira ku Southeast Asia, Middle East, Africa, Latin America, European Union ndi madera ena akunja.INNOVITA imatsatira malingaliro abizinesi okhudzana ndi makasitomala, ndipo imathandizira makasitomala ndi zinthu zolondola komanso zosavuta.Zosowa za makasitomala ndi kufunafuna INNOVITA.

Njira Yachitukuko

  • Mu 2006
    ● Anakhazikitsa malo a R&D ku Beijing.
  • Mu 2011
    ● Anakhazikitsa malo opangira zinthu ku Tangshan.
  • Mu 2014
    ● Chitsimikizo cha ISO 13485.
  • Mu 2018
    ● Strategic Investment by Genesis Capital.
    ● Anayambitsa mgwirizano wapadziko lonse waukadaulo.
  • Mu 2019
    ● Strategic Investment ndi Sequoia Capital.
  • Mu 2020
    ● NMPA Yoyamba idavomereza COVID-19 IgM/IgG Combo Test.
    ● Amatumizidwa kumayiko / madera oposa 70.
    ● Anapatsidwa Mphotho Yapamwamba Kwambiri mu National Commendation Congress for Combating COVID-19 Pandemic.
    ● Kuyezetsa kwa COVID-19 IgM/IgG kudalandira Emergency Use Authorization (EUA) ndi US FDA.
  • Mu 2022
    ● Msonkhano woyamba wotsegulira pa SSE STAR Market, ndipo udzalembedwa pa China Sci-Tech Innovation Board posachedwa.
  • Nthambi

    about-us (7)

    Beijing R&D & Marketing Center

    Kukhazikitsa:2006

    Kuyikira Kwambiri:R&D, kupanga, kutsatsa kwa in-vitro diagnostic product, kuphatikiza nsanja monga immunodiagnosis, matenda a maselo, ndi tchipisi ta jini.

    Qian'an Manufacturing & Logistic Center

    Kukhazikitsa:2011

    Malo:Kuphimba dera la maekala 150, malo ozungulira 8,000 ㎡, okhala ndi mizere ingapo yopanga golide wa colloidal, ELISA, PCR.

    Chitsimikizo:ISO 13485, CE, FDA, NMPA, etc.

    Guangzhou R&D Center

    Kukhazikitsa:2020

    Kuyikira Kwambiri:R&D yaukadaulo wa IVD

    Mapulatifomu

    plate

    Marketing Network

    Pambuyo pazaka zachitukuko, Innovita ili kale ndi maukonde athunthu ogulitsa ndi mautumiki, okhala ndi njira zogulitsira zomwe zikuphimba zigawo 32 ndi zigawo kudutsa China, ndipo zatumiza kumisika yapadziko lonse lapansi monga Southeast Asia, Middle East, Africa, Latin America, Europe, ndi zina zambiri.

    Innovita 2019-nCoV Ab Test ikuwonetsedwa papulatifomu yadzidzidzi yadziko lonse yamankhwala ndi zida zamankhwala

    Pa february 28, 2020, Prime Minister Li Keqiang adayendera pulatifomu yadzidzidzi yamankhwala ndi zida zamankhwala za COVID-19.Innovita 2019-nCoV Ab Test idawonetsedwa ngati mayeso oyamba a antibody a NMPA ovomerezeka a IgM/IgG, omwe adanenedwa pa CCTV.

    about-us (26)
    about-us (11)

    Innovita 2019-nCoV Ab Test yotchulidwa ndi Academician Zhong Nanshan

    ● Madzulo a February 23, 2020, Katswiri wamaphunziro Zhong Nanshan adaulula pokambirana ndi achipatala ku Guangdong ku Guangdong kuti akathandize Jingzhou kuti bungwe la National Medical Products Administration lavomereza zida ziwiri zatsopano zoyesera za 2019-nCoV, imodzi mwa izo ndi opangidwa ndi Innovita (Tangshan) Biological Technology Co., Ltd.

    ● Chidacho chimagwiritsa ntchito njira ya golidi wa colloidal, yomwe imatha kuzindikira ma antibody a lgM m'thupi la wodwalayo.Ma antibody a lgM amatha kuzindikirika pa tsiku lachisanu ndi chiwiri la matenda a wodwala kapena tsiku la 3 chiyambireni, zomwe zimathandiza kwambiri kuti wodwalayo adziwenso.Zhong Nanshan adati: "Odwala amatha kudziwidwa mwachangu kuti awapeze bwino. Izi zitha kutithandiza kulekanitsa mwachangu anthu abwinobwino ndi omwe ali ndi kachilombo."

    about-us (15)

    Advanced Collective Award

    about-us (8)

    Kulimbana ndi Mliri

    Combating Pandemic